Overall rank by patents
#5,419
Across all tracked assignees
USPTO PatentsView assignee record - 64 granted patents across 21 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F21K (NON-ELECTRIC LIGHT SOURCES USING LUMINESCENCE; LIGHT SOURCES USING ELECTROCHEMILUMINESCENCE; LIGHT SOURCES USING CHARGES OF COMBUSTIBLE MATERIAL; LIGHT SOURCES USING SEMICONDUCTOR DEVICES AS LIGHT-GEN).
The verdict
ilumisys holds 64 US patents across 21 technology areas, rank #5,419 of 50,000 tracked assignees.
Ilumisys, Inc. has been granted 64 US utility patents between 2015 and 2022, placing Ilumisys, Inc. at rank #5,419 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.9 claims per patent with primary concentration in F21K (NON-ELECTRIC LIGHT SOURCES USING LUMINESCENCE; LIGHT SOURCES USING ELECTROCHEMILUMINESCENCE; LIGHT SOURCES USING CHARGES OF COMBUSTIBLE MATERIAL; LIGHT SOURCES USING SEMICONDUCTOR DEVICES AS LIGHT-GEN). As a US Corporation, Ilumisys, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, ilumisys sits between X-FAB Semiconductor Foundries Gmbh (64 patents, rank #5,415) and Abbvie Biotechnology Ltd. (63 patents, rank #5,423) - the closest US assignees by grant volume. The composite Innovation Score of 41.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 15 grants, compared with 49 in the 2015–2019 window, a -69% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ilumisys, Inc.'s 16.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ilumisys, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
X-FAB SEMICONDUCTOR FOUNDRIES GMBH
64 patents
ZF Automotive UK Limited
64 patents
Zazzle Inc.
64 patents
Zealand Pharma A/S
64 patents
iLumisys, Inc.
64 patents
ASAPP, INC.
63 patents
ASIA OPTICAL INTERNATIONAL LTD.
63 patents
ATLANTIC INERTIAL SYSTEMS LIMITED
63 patents
AbbVie Biotechnology Ltd.
63 patents
What this shows Ilumisys holds 64 patents at rank #5,419, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,419 in granted patent volume.
Other assignees with the most granted patents in Ilumisys's primary technology class.
ilumisys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 32% higher than 68% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 12 | 18.8% |
| 2016 | 8 | 12.5% |
| 2017 | 14 | 21.9% |
| 2018 | 9 | 14.1% |
| 2019 | 6 | 9.4% |
| 2020 | 6 | 9.4% |
| 2021 | 6 | 9.4% |
| 2022 | 3 | 4.7% |
Top 15 of 21 technology areas
Overall rank by patents
#5,419
Across all tracked assignees
41.9 out of 100
How to use this portfolio
ilumisys's 64 grants land it in the top 32% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.